Q-901 is under clinical development by Qurient and currently in Phase II for Metastatic Ovarian Cancer. According to GlobalData, Phase II drugs for Metastatic Ovarian Cancer have a 26% phase ...

PAX-1 is under clinical development by Komipharm International and currently in Phase I for Metastatic Ovarian Cancer.

The top 5 ovarian cancer articles of 2024 covered topics such as the impact of air pollution on ovarian cancer risk, treatment strategies for patients with liver metastases, and the benefits of early ...

There is a significant overlap between some symptoms of ovarian cancer, irritable bowel syndrome (IBS) and premenstrual ...

A new international study led by researchers at Karolinska Institutet in Sweden shows that AI-based models can outperform ...

Ovarian cancer is when abnormal cells in the ovary, fallopian tube or peritoneum begin to grow and divide in an uncontrolled way. They eventually form a growth (tumour). If not caught early, cancer ...

Ovarian cancer is when abnormal cells in the ovary, fallopian tube or peritoneum begin to grow and divide in an uncontrolled way. They eventually form a growth (tumour). If not caught early, cancer ...

Ovarian cancer cells exploit cell competition by altering Flower protein isoforms in stromal cells, promoting tumor survival ...

Discover crucial early warning signs of ovarian cancer that may surface during or after meals. Learn about symptoms, risk ...